Ginkgo Bioworks settlements

Ginkgo Bioworks Holdings is the subject of a $17,750,000 securities class action settlement, known as the Ginkgo Securities Litigation, targeting investors who purchased shares through the 2021 Proxy/Registration Statement or on the open market between May 11, 2021 and October 5, 2021. The settlement fund totals $17,750,000, with a recovery of approximately $0.10 per share before deductions. The verified claim deadline was November 21, 2024 — this record preserves the official settlement terms and claim requirements for affected shareholders.

Check what you may be owed Free · takes 20 seconds

Published directory

1 published record

Proof required

False Advertising

Ginkgo Securities Litigation

Ginkgo Bioworks agreed to pay $17.75 million to settle a securities class action tied to its 2021 SPAC merger. The case covered investors who acquired shares through the merger's proxy statement, were solicited to approve the merger, or purchased Ginkgo securities between May 11, 2021 and October 5, 2021. The claim filing window has closed.

Claim window closed Evidence-verified

Related companies with published settlements

Share this collection — free to repost with a link back.

There may be money with your name on it.

Free to browse and track. Every record shows its official-evidence status — and you open the official claim form yourself.

Check what you may be owed Browse all settlements